Filing search / Legend Biotech Corporation / "Bonus"

6-K

LEGN Legend Biotech Corporation

3 Oct 22

Legend Biotech Corporation 6-K

4:02pm

bonus with a target of 35% (the “Annual Bonus”) of her then-current base salary (the “Target Amount”). Under the Employment Agreement, Ms. Macomber’s … eligibility for the Annual Bonus will be based upon her performance, business conditions at the Company, and the terms of any applicable bonus plan

6-K

EX-10.1

LEGN Legend Biotech Corporation

3 Oct 22

Legend Biotech Corporation 6-K

4:02pm

), is subject to increase (but not decrease) in the discretion of the Compensation Committee of the Board. - 1 - (b) Annual Discretionary Bonus … . The Executive will be considered for an annual performance bonus with respect to each fiscal year of the Executive’s employment with the Company. The amount

6-K

EX-10.1

LEGN Legend Biotech Corporation

4 Aug 22

Legend Biotech Appoints Three New Directors and Elects New Chairman of the Board

4:18pm

(but not decrease) in the discretion of the Board. (b) Annual Discretionary Bonus. The Executive will be considered for an annual performance bonus … with respect to each fiscal year of the Executive’s employment with the Company. The amount, terms and conditions of such bonus (if any) are subject

6-K

LEGN Legend Biotech Corporation

4 Aug 22

Legend Biotech Appoints Three New Directors and Elects New Chairman of the Board

4:18pm

annual base salary is $700,000 and Dr. Huang is eligible for a discretionary annual cash bonus with a target of 75% (the “Annual Bonus”) of Dr. Huang’s … then-current base salary (the “Target Amount”). Under the Employment Agreement, Dr. Huang’s eligibility for the Annual Bonus will be based upon

F-3

kvuhm5pp84dps 25ra

2 Jul 21

Shelf registration (foreign)

7:36am

20-F

je1k4hl4hpl sk1s

2 Apr 21

Annual report (foreign)

8:10am

6-K

EX-10.1

ok9bckh tivv18f

30 Dec 20

Current report (foreign)

6:50am

6-K

lz2voosk6 ma449uix6

30 Dec 20

Current report (foreign)

6:50am

6-K

i0730uoi0

3 Aug 20

Legend Biotech Announces Chief Executive Officer Transition

6:07am

S-8

EX-4.1

55qx9vsdery8u9gd

26 Jun 20

Registration of securities for employees

4:11pm

424B4

86qq5oqh0p47k

8 Jun 20

Prospectus supplement with pricing info

9:07am

F-1/A

b9658xc2

29 May 20

Registration statement (foreign) (amended)

8:32am

F-1/A

EX-3.2

mwofgpxcg48bn

29 May 20

Registration statement (foreign) (amended)

8:32am

F-1

EX-10.4

8usuxniew8ewcbvk3igb

13 May 20

Registration statement (foreign)

4:41pm

F-1

EX-10.1

437quio

13 May 20

Registration statement (foreign)

4:41pm

F-1

p481w

13 May 20

Registration statement (foreign)

4:41pm

F-1

EX-10.3

dqw0volejm93p

13 May 20

Registration statement (foreign)

4:41pm

DRS/A

f8smai0

8 May 20

Draft registration statement (amended)

12:00am

DRS/A

EX-10.1

u6kiyx

8 May 20

Draft registration statement (amended)

12:00am